ArticleFrontiers in medicine2026
Stakeholder engagement in genetics research development in diverse urban communities in the Midwestern United States: process and considerations.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The inclusion of individuals from diverse backgrounds is essential to enhancing the generalizability and interpretability of genetic testing results. It is imperative to foster stakeholder engagement at all steps in the research process in diverse communities, given past and present experiences of marginalization and discrimination in healthcare research. A stakeholder engagement workshop was convened to provide input on study design and community priorities for genetic research in diverse communities. Methods: Seventeen stakeholders including primary care providers (PCP) and patient advocates from diverse communities provided anonymous quantitative (ranking exercises) and qualitative (group discussion) input during a 2-h web-based workshop. Stakeholders discussed the following topics: prioritization of conditions to include in community-based genetic screening research and considerations for genetic research development and design in diverse communities. Emergent themes were noted and summarized to inform future research development. Results: Community stakeholder discussion themes included: rationale for conditions to include in community-based genetic screening, strategies for community trust-building, the importance of actionability and support following results, provision of informational support related to genetic testing privacy issues and protections, and inclusion of genetic testing education for both PCPs and community members. Discussion: During this workshop, stakeholder input addressed considerations across the research continuum from study conceptualization to the application of findings in diverse community settings. Stakeholders' comments provide valuable insights on the development of a genetic screening program that incorporates their input from the beginning to beyond the completion of the study period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.